TIDMIDH

RNS Number : 2550Z

Immunodiagnostic Systems Hldgs PLC

13 March 2017

Immunodiagnostic Systems Holdings plc.

13 March 2017

Further re CEO Appointment

Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market confirms that incoming CEO, Regis Duval, is the beneficial owner of 29,397 ordinary shares of 2p each in the Company. This disclosure is made in accordance with AIM Rule 17. Regis Duval acquired these shares prior to joining IDS.

For further information:

   Immunodiagnostic Systems Holdings plc                              Tel: +44 (0) 191 519 0660

Paul Martin, Group Finance Director

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAGGURPWUPMURW

(END) Dow Jones Newswires

March 13, 2017 04:31 ET (08:31 GMT)

Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Immunodiagnostic Systems Charts.
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Immunodiagnostic Systems Charts.